Article Finder
Browse our vast collection of articles. Simply select a category on the left and find a list of related articles on the right.
Article Category
Article Title
- High or Low Blood Pressure May Raise the Risk of Dementia
- How Alcohol Might Affect Your Dementia Risk
- The Hidden Costs of Alzheimer’s Disease
- Susceptible to Scams? It May Be an Early Sign of Alzheimer’s Disease
- Alzheimer’s Caregivers May Benefit from Happiness Training
- Giving Up the Guns When a Family Member Has Alzheimer’s
- Care Management Program Is Reducing Need for Anti-anxiety Medication and Visits to the Hospital/Emergency Room
- Talking to a Loved One With Alzheimer’s
- 10 Powerful Ways to Commemorate Alzheimer’s Awareness Month
- Making the Most of Mealtimes for People With Alzheimer’s
- FOR MORE ARTICLES CLICK HERE
- Air Pollution Tied to Alzheimer’s Brain Changes
- The Tau of Alzheimer’s
- Anemia Tied to Alzheimer’s Risk
- ‘Squeezed’ Blood Vessels in the Brain May Contribute to Alzheimer’s Onset
- Hormone Therapy for Prostate Cancer Tied to Alzheimer’s Disease Risk
- Lack of Deep Sleep Tied to Alzheimer’s Brain Changes
- Inflammation in Middle Age Tied to Thinking and Memory Problems Later
- Frailty May Increase Susceptibility to Alzheimer’s Disease
- Intensive Blood Pressure Control May Help Keep Memory Sharp
- Inflammation May Spur the Development of Alzheimer’s Disease
- FOR MORE ARTICLES CLICK HERE
- Take Your Blood Pressure Meds. It May Reduce Your Alzheimer’s Risk.
- Drug Company to Pursue Approval of Aducanumab, New Drug for Alzheimer’s
- Drugs May Not Be the Best Choice for Easing the Agitation of Alzheimer’s
- Alzheimer’s Drug May Lead to Life-Threatening Muscle Disease
- Opioid Painkillers Increase Pneumonia Risk in People With Alzheimer’s Disease
- Drug Companies Halt Trials of Aducanumab for Alzheimer’s Disease
- Diabetes Treatments May Help Ward Off Alzheimer’s Disease
- Can Mushrooms Help Your Memory?
- Buyer Beware: Dietary Supplement’s Won’t Cure Alzheimer’s Disease
- Experimental Drug, Fails to Benefit Alzheimer’s Patients
- FOR MORE ARTICLES CLICK HERE
- Obesity at Midlife Tied to Increased Dementia Risk
- Reading and Writing May Be Good for the Brain
- Ski Study Shows How Exercise May Aid the Brain
- How Light May Help People with Alzheimer’s Disease
- Trans Fats Tied to Increased Alzheimer’s Risk
- New Guidelines Urge a Healthy Lifestyle to Prevent Dementia
- At Genetic Risk for Alzheimer’s Disease? A Healthy Lifestyle May Help
- Exercise Can Help Keep the Brain ‘Young’
- Fighting Gum Disease May Aid in Fight Against Alzheimer’s Disease
- Brain Scans Aid in Management of Alzheimer’s Disease
- FOR MORE ARTICLES CLICK HERE
- A Rare Genetic Mutation May Protect Against Alzheimer’s
- Income Drops in Young Adulthood May Impair Brain Health
- Blood Test for Alzheimer’s Grows Closer
- Are We Getting Closer to an Alzheimer’s Vaccine?
- Why More Women Than Men Have Alzheimer’s Disease
- Scientists get a ‘total surprise’ and a promising new clue for how to cure Alzheimer’s
- Some 44 Million People Have Alzheimer’s Worldwide
- Nearly 14 Million Americans Will Have Alzheimer’s Disease by 2060
- Alzheimer’s Rates Could Double in Coming Decades
- Combining Care Program With Medication Reduces Alzheimer’s Symptoms By 750%
- FOR MORE ARTICLES CLICK HERE
- The Fisher Center for Alzheimer’s Research Foundation Earns Coveted 4-Star Rating from Charity Navigator for the 8th Consecutive Year
- Fisher Center For Alzheimer’s Research Foundation Wins Fall 2018 Digital Health Awards®
- Fisher Center for Alzheimer’s Research Foundation Earns Gold Seal of Transparency from GuideStar
- The Fisher Center for Alzheimer’s Research Foundation Earns Coveted 4-Star Rating from Charity Navigator for the 7th Consecutive Year
- Hear Kent Karosen, President and CEO of the Fisher Center for Alzheimer’s Research Foundation, describe his new book and the power of art therapy
- Fisher Center Scientists link a Mutation That Protects Against the Development of Alzheimer’s Disease
- Newly Inducted Into the Basketball Hall of Fame, Shaquille O’Neal, Joins the Fisher Center for Alzheimer’s Research Foundation to Raise Funds for Groundbreaking Research in the Quest for a Cure
- Pat Summitt, legendary women’s basketball coach, dies at 64
- Celebrating the life of Nancy Reagan for her Impact on the Fight to end Alzheimer’s
- WRNN Interview
- FOR MORE ARTICLES CLICK HERE
Alzheimer’s Fighter in Your Spice Rack?
January 18, 2005
January 18, 2005
Curcumin, the yellow pigment in the herb turmeric and a key ingredient in curry spice, may have benefits against Alzheimer’s disease, a new study reports. The study showed that curcumin reduced the tendency of beta amyloid to form sticky clumps in the brains of mice that had been genetically altered to develop amyloid plaques like those found in Alzheimer’s disease patients. Beta amyloid is the potentially toxic substance believed to cause the brain damage of Alzheimer’s disease, and its tendency to form sticky clumps results in its toxic effects. Scientists are hopeful that the spice, or some form of medication derived from it, may have benefits for people who suffer from Alzheimer’s disease.
Researchers at the University of California, Los Angeles – Veterans Affairs Center also found that the spice broke up plaques that were already present in the mouse brains. Curcumin was also able to reach and penetrate the mouse brains after being ingested.
Earlier studies suggest that curcumin is a powerful antioxidant, protecting cells from damage throughout the body, including the brain. The spice also has inflammation-fighting properties. Increasingly, inflammation is thought to contribute to many maladies of old age, including heart disease and Alzheimer’s. However, it is not clear what property of curcumin causes it to prevent plaque buildup.
“The prospect of finding a safe and effective new approach to both prevention and treatment of Alzheimer’s disease is tremendously exciting,” said study leader Gregory Cole, professor of medicine and neurology at the David Geffen School of Medicine at UCLA. “Curcumin has been used for thousands of years as a safe c in a variety of ailments as part of Indian traditional medicine. Recent successful studies in animal models support a growing interest in its possible use for diseases of aging involving oxidative damage and inflammation like Alzheimer’s, cancer, and heart disease. What we really need, however, are clinical trials to establish safe and effective doses in aging patients.”
The possible benefits of curry are further bolstered by population studies. In countries like India, where curry is a staple of the everyday diet, rates of Alzheimer’s disease may be lower than they are in the United States. The prevalence of Alzheimer’s in one Indian community was four times lower among men and women in their 70s than it is in seniors in the U.S. It is not known, however, whether people in India are less likely to develop Alzheimer’s disease or whether those who do develop it die quickly and are not counted in the population studies. It should also be pointed out that diets rich in curry are not the only difference between Indian populations and populations in the U.S. and other countries. If there really is less Alzheimer’s disease in India it could result from things unrelated to curry.
The UCLA Alzheimer’s Disease Research Center is starting human clinical trials to further evaluate the possible protective and therapeutic effects of curcumin.
By www.ALZinfo.org, The Alzheimer’s Information Site. Reviewed by William J. Netzer, Ph.D., Fisher Center for Alzheimer’s Research Foundation at The Rockefeller University.
Source:
F. Yang, G. P. Lim, A. N. Begum, et al: “Curcumin inhibits formation of A oligomers and fibrils and binds plaques and reduces amyloid in vivo.” Journal of Biological Chemistry, publishied online December 7, 2004.
